Avihingsanon A - Search Results

1

Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study - PEDA Study.

Sapsirisavat V, Vongsutilers V, Thammajaruk N, Pussadee K, Riyaten P, Kerr S, Avihingsanon A, Phanuphak P, Ruxrungtham K; PEDA study team. Sapsirisavat V, et al. Among authors: avihingsanon a. PLoS One. 2016 Jun 20;11(6):e0157039. doi: 10.1371/journal.pone.0157039. eCollection 2016. PLoS One. 2016. PMID: 27322409 Free PMC article.

2

High prevalence of indinavir-associated renal complications in Thai HIV-infected patients.

Avihingsanon A, Avihingsanon Y, Darnpornprasert P, Kerr S, Ungsedhapand C, Duncombe C, Ubolyam S, Ruxrungtham K, Phanuphak P. Avihingsanon A, et al. Among authors: avihingsanon y. J Med Assoc Thai. 2006 Aug;89 Suppl 2:S21-7. J Med Assoc Thai. 2006. PMID: 17044450

3

Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens.

Kerr SJ, Duncombe C, Avihingsanon A, Ananworanich J, Boyd M, Sopa B, Medtech B, Chuenyam T, Cooper DA, Lange JM, Phanuphak P, Ruxrungtham K. Kerr SJ, et al. Among authors: avihingsanon a. J Int Assoc Physicians AIDS Care (Chic). 2007 Mar;6(1):36-46. doi: 10.1177/1545109706295946. J Int Assoc Physicians AIDS Care (Chic). 2007. PMID: 17329503

4

Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults.

van der Lugt J, Autar RS, Ubolyam S, Garcia EF, Sankote J, Avihingsanon A, Chuenyam T, Cooper DA, Lange J, Phanuphak P, Wit F, Ruxrungtham K, Burger D; HIV-NAT 019 Study Team. van der Lugt J, et al. Among authors: avihingsanon a. J Antimicrob Chemother. 2008 May;61(5):1145-53. doi: 10.1093/jac/dkn050. Epub 2008 Feb 18. J Antimicrob Chemother. 2008. PMID: 18285316 Clinical Trial.

5

Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin.

Avihingsanon A, Manosuthi W, Kantipong P, Chuchotaworn C, Moolphate S, Sakornjun W, Gorowara M, Yamada N, Yanai H, Mitarai S, Ishikawa N, Cooper DA, Phanuphak P, Burger D, Ruxrungtham K. Avihingsanon A, et al. Antivir Ther. 2008;13(4):529-36. Antivir Ther. 2008. PMID: 18672531 Clinical Trial.

6

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.

Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P, Marks P, Sasadeusz J, Cooper DA, Bowden S, Locarnini S, Ruxrungtham K, Dore GJ. Matthews GV, et al. Among authors: avihingsanon a. Hepatology. 2008 Oct;48(4):1062-9. doi: 10.1002/hep.22462. Hepatology. 2008. PMID: 18697216 Clinical Trial.

7

A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults.

Avihingsanon A, van der Lugt J, Kerr SJ, Gorowara M, Chanmano S, Ohata P, Lange J, Cooper DA, Phanuphak P, Burger DM, Ruxrungtham K. Avihingsanon A, et al. Clin Pharmacol Ther. 2009 Apr;85(4):402-8. doi: 10.1038/clpt.2008.244. Epub 2008 Dec 31. Clin Pharmacol Ther. 2009. PMID: 19118378

8

Gemini: a noninferiority study of saquinavir/ritonavir versus lopinavir/ritonavir as initial HIV-1 therapy in adults.

Walmsley S, Avihingsanon A, Slim J, Ward DJ, Ruxrungtham K, Brunetta J, Bredeek UF, Jayaweera D, Guittari CJ, Larson P, Schutz M, Raffi F. Walmsley S, et al. Among authors: avihingsanon a. J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):367-74. doi: 10.1097/QAI.0b013e318198a815. J Acquir Immune Defic Syndr. 2009. PMID: 19214123 Clinical Trial.

9

Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals.

van der Lugt J, Gorowara M, Avihingsanon A, Burger D, Ananworanich J, Sringam K, Kerr S, Wit F, Lange J, Ruxrungtham K. van der Lugt J, et al. Among authors: avihingsanon a. AIDS. 2009 Jun 1;23(9):1176-9. doi: 10.1097/QAD.0b013e32832b4461. AIDS. 2009. PMID: 19451794 Clinical Trial.

10

Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals.

van der Lugt J, Lange J, Avihingsanon A, Ananworanich J, Sealoo S, Burger D, Gorowara M, Phanuphak P, Ruxrungtham K. van der Lugt J, et al. Among authors: avihingsanon a. Antivir Ther. 2009;14(7):1001-4. doi: 10.3851/IMP1410. Antivir Ther. 2009. PMID: 19918104 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page